Skip to main content
Equibles
PROF logo

PROF · Profound Medical Corp. · Earnings Call Transcripts & Audio

Track PROF — free

Use PROF with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research PROF.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$5.80 +0.08 (+1.40%) At close · Sep 30
Rebalance outlook locked
Market Cap
$210.43M
Shares
36.53M
Volume · Sep 30 106.88K Avg daily vol (3M) 118.74K

Profound Medical Corp. Earnings Call Transcripts

Quarterly earnings calls for Profound Medical Corp. (PROF), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.

Pull transcripts and briefs through the earnings call transcript API or MCP →

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
· $1.44M −$6.58M '24 Q1 24-03-31 · $2.23M −$6.92M '24 Q2 24-06-30 · $2.83M −$9.37M '24 Q3 24-09-30 · $4.18M −$4.95M '24 Q4 25-03-07 ▲82.1% $2.62M −$10.72M '25 Q1 25-05-08 ▼1% $2.21M −$15.70M '25 Q2 25-08-14 ▲86.8% $5.29M −$7.98M '25 Q3 25-10-07 ▲43.1% $5.98M −$8.17M '25 Q4 26-03-05 ▲103.6% $5.34M −$7.05M '26 Q1 26-05-07 LATEST ▲12.3% $2.48M −$9.54M '26 Q2 26-08-06
Earnings call
FY26 · Q2
2026-08-06
Profound Medical Corp. (PROF) Q2 2026 Earnings Call
Revenue
$2.48M
▲ 12.3% YoY
Diluted EPS
$-0.26
Gross margin
78.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-05-07
Profound Medical Corp. (PROF) Q1 2026 Earnings Call
Revenue
$5.34M
▲ 103.6% YoY
Diluted EPS
$0.19
▼ 47.2% YoY
Gross margin
71.8%
Rev · 7q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-03-05
Profound Medical Corp. (PROF) Q4 2025 Earnings Call Transcript
Confident tone CAPTAIN trial and clinical evidence Revenue growth and financials Installed base growth and utilization targets
Revenue
$5.98M*
▲ 43.1% YoY
Gross margin
66.8%
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-10-07
Profound Medical Corp. (PROF) Q3 2025 Earnings Call Transcript
Confident tone TULSA-AI Volume Reduction software launch BPH market expansion Revenue growth and profitability trajectory
Revenue
$5.29M
▲ 86.8% YoY
Diluted EPS
$0.26
▼ 31.6% YoY
Gross margin
74.3%
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-14
Profound Medical Corp. (PROF) Q2 2025 Earnings Call Transcript
Positive tone Software upgrade / procedure time CAPTAIN trial milestones Sales pipeline and funnel
Revenue
$2.21M
▼ 1% YoY
Diluted EPS
$-0.52
▼ 285.7% YoY
Gross margin
73.2%
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-08
Profound Medical Corp. (PROF) Q1 2025 Earnings Call Transcript
Confident tone TULSA-PRO clinical differentiation and CAPTAIN trial TULSA+ bundled offering with MRI partners Pipeline of cancer centers and adoption cycle
Revenue
$2.62M
▲ 82.1% YoY
Diluted EPS
$0.36
▲ 33.3% YoY
Gross margin
70.7%
Rev · 4q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Capital Markets Day
Investor event
2025-04-28
Profound Medical Corp. (PROF) April 2025 Capital Markets Day Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY24 · Q4
2025-03-07
Profound Medical Corp. (PROF) Q4 2024 Earnings Call Transcript
Confident tone TULSA-PRO technology and precision Commercial organization and capital sales model Reimbursement and Medicare payments
Revenue
$4.18M*
Gross margin
70.9%
Rev · 3q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-09-30
Profound Medical Corp. (PROF) Q3 2024 Earnings Call Transcript
Confident tone TULSA procedure and clinical flexibility Reimbursement and CPT Category 1 codes TULSA Plus and Siemens partnership
Revenue
$2.83M
Diluted EPS
$0.38
Gross margin
63.1%
Rev · 3q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-06-30
Profound Medical Corp. (PROF) Q2 2024 Earnings Call Transcript
Positive tone Real-world TULSA utilization Reimbursement and CPT codes Procedure throughput and economics
Revenue
$2.23M
Diluted EPS
$0.28
Gross margin
63.6%
Rev · 2q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-03-31
Profound Medical Corp. (PROF) Q1 2024 Earnings Call Transcript
Confident tone Recurring revenue and utilization growth Indication breadth and patient spectrum Reimbursement and CMS pricing
Revenue
$1.44M
Diluted EPS
$0.27
Gross margin
60.2%
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2023-12-31
Profound Medical Corp. (PROF) Q4 2023 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-09-30
Profound Medical Corp. (PROF) Q3 2023 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-06-30
Profound Medical Corp. (PROF) Q2 2023 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-03-31
Profound Medical Corp. (PROF) Q1 2023 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2022-12-31
Profound Medical Corp. (PROF) Q4 2022 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-09-30
Profound Medical Corp. (PROF) Q3 2022 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-06-30
Profound Medical Corp. (PROF) Q2 2022 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-03-31
Profound Medical Corp. (PROF) Q1 2022 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2021-12-31
Profound Medical Corp. (PROF) Q4 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-09-30
Profound Medical Corp. (PROF) Q3 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-06-30
Profound Medical Corp. (PROF) Q2 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-03-31
Profound Medical Corp. (PROF) Q1 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2020-12-31
Profound Medical Corp. (PROF) Q4 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-09-30
Profound Medical Corp. (PROF) Q3 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-06-30
Profound Medical Corp. (PROF) Q2 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-03-31
Profound Medical Corp. (PROF) Q1 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Showing 1–27 of 27 earnings calls
Key facts CIK 1628808 CUSIP 74319B502 13F (30d) 1 filings 1 filers Visit website Investor relations